Artiva Biotherapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $0.0 | $0.3 | $32.9 | — |
| Operating income | -$89.8 | -$67.3 | -$30.7 | — |
| Net income | -$83.9 | -$65.4 | -$28.7 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$79.3 | -$55.7 | -$50.7 | — |
Shares outstanding 24.7M
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.